Joseph D. DiDomenico

Glioblastoma-Derived IL6 Induces Immunosuppressive Peripheral Myeloid Cell PD-L1 and Promotes Tumor Growth

Jonathan B. Lamano, Jason Balquidera Lamano, Yuping D. Li et al. · Clinical Cancer Research · 2019 · 217 citations · Full text

Life Sciences, Immunology, Oncology +14

The immune checkpoint protein PD-L1 induces and maintains regulatory T cells in glioblastoma

Joseph D. DiDomenico, Jonathan B. Lamano, Daniel E. Oyon et al. · OncoImmunology · 2018 · 112 citations · Full text

Life Sciences, Immunology, Oncology +17

Bortezomib‐induced sensitization of malignant human glioma cells to vorinostat‐induced apoptosis depends on reactive oxygen species production, mitochondrial dysfunction, Noxa upregulation, Mcl‐1 cleavage, and DNA damage

Daniel R. Premkumar, Esther P. Jane, Naomi R. Agostino et al. · Molecular Carcinogenesis · 2011 · 60 citations · Full text

Medicine, Oncology, Pharmacology +16

ABT-737 Synergizes with Bortezomib to Induce Apoptosis, Mediated by Bid Cleavage, Bax Activation, and Mitochondrial Dysfunction in an Akt-Dependent Context in Malignant Human Glioma Cell Lines

Daniel R. Premkumar, Esther P. Jane, Joseph D. DiDomenico et al. · Journal of Pharmacology and Experimental Therapeutics · 2012 · 39 citations · Full text

Medicine, Oncology, Pharmacology +17

Thirty-day readmission rate and risk factors for patients undergoing single level elective anterior lumbar interbody fusion (ALIF)

Roxanna M. García, Winward Choy, Joseph D. DiDomenico et al. · Journal of Clinical Neuroscience · 2016 · 34 citations

Medicine, Orthopaedic Surgery, Orthopedic Surgery +12